Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness of Upadacitinib in Patients With Axial Spondyloarthritis Suffering From Typical Disease Activity and Pain in a Real-World Setting

NCT05094128 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.

NCT NCT05094128
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05094128 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness of Upadacitinib in Patients With Axial Spondyloarthritis Suffering From Typical Disease Activity and Pain in a Real-World Setting
Lead sponsor
AbbVie
Phase
Observational
Overall status
Active, not recruiting
Start date
November 22, 2021
Completion date
April 30, 2027
Enrollment
338 (actual)
Sites
72

Conditions

As the registry lists them; a condition with its own page is linked.

axial spondylarthritis (r-axspa)